Inventor · disambiguated record
Shaw-Fen Sylvia Hu
Also filed as: HU SHAW-FEN S · HU SHAW-FEN SYLVIA
29 granted patents·11 pending applications·646 citations·filing 1988–2024
97Inventor score
Top patents by PatentIndex Score
40 records- 0196US7947809B2Compositions and methods relating to glucagon receptor antibodiesAMGEN INC·Filed 2007·Granted May 24, 2011·46 cites·7 claims
- 0296US5162215AMethod of gene transfer into chickens and other avian speciesAMGEN INC·Filed 1988·Granted Nov 10, 1992·236 cites·12 claims
- 0395US9102731B2Human CGRP receptor binding proteinsBOONE THOMAS C·Filed 2009·Granted Aug 11, 2015·39 cites·15 claims
- 0495US7833979B2Toxin peptide therapeutic agentsAMGEN INC·Filed 2006·Granted Nov 16, 2010·45 cites·31 claims
- 0594US8907071B2Toxin peptide therapeutic agentsSULLIVAN JOHN K·Filed 2010·Granted Dec 9, 2014·61 cites·24 claims
- 0691US9862771B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2015·Granted Jan 9, 2018·8 cites·36 claims
- 0791US2025129172A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2024·Application pending·0 cites
- 0890US7888482B2Antibodies that bind PAR-2AMGEN INC·Filed 2007·Granted Feb 15, 2011·26 cites·8 claims
- 0989US8158759B2Compositions and methods relating to glucagon receptor antibodiesYAN HAI·Filed 2011·Granted Apr 17, 2012·13 cites·7 claims
- 1089US7834164B2DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expressionAMGEN INC·Filed 2007·Granted Nov 16, 2010·9 cites·8 claims
- 1189US7820623B2Conjugated toxin peptide therapeutic agentsAMGEN INC·Filed 2007·Granted Oct 26, 2010·10 cites·23 claims
- 1289US6210924B1Overexpressing cyclin D 1 in a eukaryotic cell lineAMGEN INC·Filed 1999·Granted Apr 3, 2001·73 cites·18 claims
- 1389US2025163160A1Human Antigen Binding Proteins That Bind Beta-Klotho, FGF Receptors and Complexes ThereofAMGEN INC·Filed 2024·Application pending·0 cites
- 1486US9284378B2Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereofHU SHAW-FEN SYLVIA·Filed 2010·Granted Mar 15, 2016·9 cites·3 claims
- 1585US8043829B2DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expressionAMGEN INC·Filed 2007·Granted Oct 25, 2011·6 cites·19 claims
- 1684US9517264B2Human FGF receptor and β-Klotho binding proteinsFACHINI ROGER·Filed 2011·Granted Dec 13, 2016·19 cites·41 claims
- 1782US8357367B2Antibodies that bind PAR-2AMGEN INC·Filed 2008·Granted Jan 22, 2013·4 cites·5 claims
- 1882US7910102B2Methods of using conjugated toxin peptide therapeutic agentsAMGEN INC·Filed 2007·Granted Mar 22, 2011·4 cites·12 claims
- 1981US11248052B2Antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorAMGEN INC·Filed 2019·Granted Feb 15, 2022·1 cites·5 claims
- 2077US12134652B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Nov 5, 2024·0 cites·12 claims
- 2177US12122841B2Human CGRP receptor binding proteinsAMGEN INC·Filed 2020·Granted Oct 22, 2024·0 cites·18 claims
- 2277US10570205B2Human antigen binding proteins that bind β-Klotho, FGF receptors and complexes thereofAMGEN INC·Filed 2016·Granted Feb 25, 2020·1 cites·13 claims
- 2377US7390781B2Methods of using truncated glial cell line-derived neurotrophic factorAMGEN INC·Filed 2004·Granted Jun 24, 2008·6 cites·20 claims
- 2476US9574002B2Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptorLI YANG·Filed 2012·Granted Feb 21, 2017·2 cites·14 claims
- 2575US9493577B2Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereofAMGEN INC·Filed 2016·Granted Nov 15, 2016·1 cites·7 claims
- 2675US7611865B2Polynucleotides encoding truncated glial cell line-derived neurotrophic factorAMGEN INC·Filed 2004·Granted Nov 3, 2009·5 cites·9 claims
- 2773US12116413B2Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereofAMGEN INC·Filed 2020·Granted Oct 15, 2024·0 cites·4 claims
- 2870US6184200B1Truncated glial cell line-derived neurotrophic factorAMGEN INC·Filed 1995·Granted Feb 6, 2001·21 cites·21 claims
- 2964US2018142029A1Human cgrp receptor binding proteinsAMGEN INC·Filed 2017·Application pending·0 cites
- 3062US8287872B2Methods for treating inflammatory conditions using antibodies that bind PAR-2VIRCA GEORGE DUKE·Filed 2011·Granted Oct 16, 2012·1 cites·5 claims
- 3160US2013071410A1Human CGRP Receptor Binding ProteinsBOONE THOMAS C·Filed 2012·Application pending·0 cites
- 3259US2004214776A1Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factorAMGEN INC·Filed 2004·Application pending·0 cites
- 3357US2011251267A1Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factorAMGEN INC·Filed 2011·Application pending·0 cites
- 3455US2014170166A1Antigen binding proteins that bind par-2AMGEN INC·Filed 2013·Application pending·0 cites
- 3552US8470556B2Nucleic acids that encode antigen binding proteins that bind PAR-2VIRCA G DUKE·Filed 2012·Granted Jun 25, 2013·0 cites·16 claims
- 3652US2017183412A1Human Antigen Binding Proteins That Bind To a Complex Comprising beta-Klotho and an FGF ReceptorAMGEN INC·Filed 2017·Application pending·0 cites
- 3751US10526411B2Methods and compositions relating to anti-CCR7 antigen binding proteinsAMGEN INC·Filed 2017·Granted Jan 7, 2020·0 cites·5 claims
- 3850US2013189281A1Antibodies that bind par-2AMGEN INC·Filed 2012·Application pending·0 cites
- 3949US2016031997A1Methods and compositions relating to anti-ccr7 antigen binding proteinsAMGEN INC·Filed 2014·Application pending·0 cites
- 4031US2012231006A1Anti-orai1 antigen binding proteins and uses thereofNGUYEN HUNG Q·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shaw-Fen Sylvia Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →